dc- 4740461334061v1 

IN THE UNITED STATES DISTRICT COURT 

FOR THE NORTHERN DISTRICT OF ILLINOIS 

EASTERN DIVISION 

TAP PHARMACEUTICAL PRODUCTS INC., 

TAKEDA CHEMICAL INDUSTRIES, LTD., and 

WAKO PURE CHEMICAL INDUSTRIES, LTD., 

Plaintiffs, 

v. 

ATRIX LABORATORIES, INC. and 

SANOFI-SYNTHELABO INC., 

Defendants. 

 

CASE NO.: 1:03 CV 7822 

JUDGE: James B. Zagel 

Magistrate Judge: Geraldine Soat 

Brown 

JOINT MOTION TO SUSPEND PROCEEDINGS 

PENDING SETTLEMENT NEGOTIATIONS 

TAP Pharmaceutical Products Inc., Takeda Pharmaceutical Company Ltd. (formerly 

Takeda Chemical Industries, Ltd.), and Wako Pure Chemical Industries, Ltd. (collectively 

"Plaintiffs"), and QLT USA, Inc. (formerly Atrix Laboratories, Inc.) and Sanofi-Synthelabo Inc. 

(collectively "Defendants") respectfully move to suspend all proceedings in the above-captioned 

case until January 19, 2007, pending settlement discussions. 

Plaintiffs and Defendants have made progress in recent settlement negotiations. They 

believe that settlement of their dispute will be assisted by suspending all further proceedings in 

the litigation for a period of time while settlement negotiations are being completed. It is hoped 

and expected that the negotiations which are presently pending will be consummated by January 

19, 2007. By granting the requested suspension, and by staying proceedings, the Court will 

promote settlement of this case. The parties will promptly move to dismiss the action if 

settlement negotiations are successful. If settlement negotiations are not successful, the parties 

will confer regarding a schedule for remaining pre-trial discovery and will promptly submit any 

agreed-upon schedule to the Court for its approval. 

Case: 1:03-cv-07822 Document #: 473 Filed: 12/22/06 Page 1 of 8 PageID #:5184
In accordance with this motion, Plaintiffs and Defendants request that the Court issue an 

order to do the following: 

(1) stay any ruling, and submission of position papers currently scheduled for December 

29, 2006, on Defendants' Motion to Dismiss Plaintiff TAP Pharmaceutical Products Inc. 

For Lack of Standing (ECF No. 404); 

(2) stay any ruling, and submission of opposition and reply papers, on Defendant Atrix 

Laboratories, Inc.'s Motion to Bar TAP Pharmaceutical Products Inc. and Takeda 

Chemical Industries, Ltd. from Seeking Lost Profits Damages (ECF No. 466); 

(3) stay discovery, including depositions, service of Defendants' expert reports, and 

service of written discovery, until January 19, 2007; 

(4) vacate the pretrial order due date of January 18, 2007 (see ECF No. 426); 

(5) vacate the pretrial conference scheduled for January 22, 2007 (see ECF No. 426); 

(6) vacate the January 29, 2007 trial date (see ECF No. 426); 

(7) if settlement negotiations are not successful by January 19, 2007, the parties will 

promptly confer regarding a schedule for remaining pre-trial discovery and submit any 

agreed-upon schedule to the Court for its approval. 

By filing this motion, the parties do not waive any right to re-open this case prior to 

January 19, 2007. Any party may move to re-open this case prior to January 19, 2007, and this 

motion will not be opposed. 

The parties appreciate the Court's attention to this case. 

A Proposed Order is attached. 

Case: 1:03-cv-07822 Document #: 473 Filed: 12/22/06 Page 2 of 8 PageID #:5185
Dated: December 22, 2006 

Respectfully submitted, 

TAP Pharmaceutical Products, Inc., Takeda 

Pharmaceutical Company Ltd., and Wako 

Pure Chemical Industries, Ltd., Plaintiffs 

By: William F. Cavanaugh, Jr. 

 Stuart E. Pollack 

 Christopher Y. Miller 

 Steve Shin 

 Laura Storto 

 Patterson Belknap Webb & Tyler LLP

 1133 Avenue of the Americas 

 New York, New York 10036-6710 

 Raymond Perkins 

 James Hilmert 

 Winston & Strawn 

 35 West Wacker Drive 

 Chicago, Illinois 60601 

Takeda Pharmaceutical Company Ltd., and 

Wako Pure Chemical Industries, Ltd., 

Plaintiffs 

By: Gregory S. Norrod 

Heidi L. Belongia 

Michael Houston 

Foley & Lardner LLP

321 North Clark Street, Suite 2800 

Chicago, Illinois 60610-4764 

Michael D. Kaminski 

Foley & Lardner LLP

3000 K Street NW, Suite 500 

Washington, DC 20007-5143 

Respectfully submitted, 

QLT USA, Inc. (formerly Atrix Laboratories, 

Inc.), Defendant 

By: /s/ Steven M. Evans_______________

Thomas R. Mulroy 

Steven M. Evans 

McGuire Woods LLP

77 West Wacker Drive, Suite 4100 

Chicago, Illinois 60601-1815 

Michael A. Jacobs 

Morrison & Foerster 

425 Market Street 

San Francisco, California 94105-2482 

Donald R. Ware 

Vickie L. Henry 

Foley Hoag LLP

155 Seaport Boulevard 

Boston, MA 02210-2600 

Sanofi-Synthelabo Inc., Defendant 

By: Bruce E. Fader 

Mara Lainie Taylor 

Proskauer Rose LLP

1585 Broadway 

New York, New York 10036 

Richard C. Pettus 

Pamela C. White 

McDermott, Will & Emery llp 

340 Madison Avenue 

New York, New York 10017 

Lazar P. Raynal 

McDermott, Will & Emery llp 

227 West Monroe 

Chicago, Illinois 60606-5096 

Case: 1:03-cv-07822 Document #: 473 Filed: 12/22/06 Page 3 of 8 PageID #:5186
 

Case: 1:03-cv-07822 Document #: 473 Filed: 12/22/06 Page 4 of 8 PageID #:5187
IN THE UNITED STATES DISTRICT COURT 

FOR THE NORTHERN DISTRICT OF ILLINOIS 

EASTERN DIVISION 

TAP PHARMACEUTICAL PRODUCTS INC., 

TAKEDA CHEMICAL INDUSTRIES, LTD., and 

WAKO PURE CHEMICAL INDUSTRIES, LTD., 

Plaintiffs, 

v. 

ATRIX LABORATORIES, INC. and 

SANOFI-SYNTHELABO INC., 

Defendants. 

 

CASE NO.: 1:03 CV 7822 

JUDGE: James B. Zagel 

Magistrate Judge: Geraldine Soat 

Brown 

 [PROPOSED] ORDER TO SUSPEND PROCEEDINGS 

PENDING SETTLEMENT NEGOTIATIONS 

Plaintiffs TAP Pharmaceutical Products Inc., Takeda Pharmaceutical Company Ltd., and 

Wako Pure Chemical Industries, Ltd., and Defendants QLT USA, Inc. and Sanofi-Synthelabo 

Inc., having filed a motion to suspend proceedings pending settlement negotiations; 

IT IS HEREBY ORDERED that: 

(1) the Court has stayed any ruling, and submission of position papers currently 

scheduled for December 29, 2006, on Defendants' Motion to Dismiss Plaintiff TAP 

Pharmaceutical Products Inc. For Lack of Standing (ECF No. 404); 

(2) the Court has stayed any ruling, and submission of opposition and reply papers, on 

Defendant Atrix Laboratories, Inc.'s Motion to Bar TAP Pharmaceutical Products Inc. 

and Takeda Chemical Industries, Ltd. from Seeking Lost Profits Damages (ECF No. 

466); 

(3) the Court has stayed discovery, including depositions, service of Defendants' expert 

reports, and service of written discovery, until January 19, 2007; 

(4) the Court has vacated the pretrial order due date of January 18, 2007 (see ECF No. 

426); 

(5) the Court has vacated the pretrial conference scheduled for January 22, 2007 (see 

ECF No. 426); 

Case: 1:03-cv-07822 Document #: 473 Filed: 12/22/06 Page 5 of 8 PageID #:5188
(6) The Court has vacated the January 29, 2007 trial date (see ECF No. 426); 

(7) if settlement negotiations are not successful by January 19, 2007, the parties will 

promptly confer regarding a schedule for remaining pre-trial discovery and submit any 

agreed-upon schedule to the Court for its approval. 

IT IS SO ORDERED. 

James Zagel 

United States District Judge 

Case: 1:03-cv-07822 Document #: 473 Filed: 12/22/06 Page 6 of 8 PageID #:5189
SERVICE LIST

Stuart E. Pollack 

Patterson, Belknap, Webb & Tyler LLP 

1133 Avenue of the Americas 

New York, New York 10036 

ph: (212) 336-2000 

fax: (212) 336-2222 

Counsel for Plaintiffs

Raymond C. Perkins 

Winston & Strawn 

35 West Wacker Drive 

Chicago, Illinois 60601 

ph: (312) 558-5600 

fax: (312) 558-5700 

Counsel for Plaintiffs 

Gregory S. Norrod

Heidi L. Belongia 

Michael Houston 

Foley & Lardner, LLP 

321 North Clark Street 

Suite 2800 

Chicago, Illinois 60610 

ph: (312) 832-4500 

fax: (312) 832-4700 

Additional Counsel for Plaintiffs, Takeda 

Chemical Industries, Ltd. and Wako Pure 

Chemical Industries, Ltd. 

Michael D. Kaminski 

Foley & Lardner, LLP 

3000 K Street, N.W. 

Suite 500 

Washington, D.C. 20007 

ph: (202) 672-5300 

fax: (202) 672-5399 

Additional Counsel for Plaintiffs, Takeda 

Chemical Industries, Ltd. and Wako Pure 

Chemical Industries, Ltd.

Richard C. Pettus 

McDermott Will & Emery 

340 Madison Avenue, 17th Floor 

New York, New York 10017 

ph: (212) 547-5505 

fax: (212) 547-5444 

Counsel for Defendant Sanofi-Synthelabo, 

Inc.

Lazar P. Raynal 

McDermott, Will & Emery LLP

227 West Monroe 

Chicago, Illinois 60606-5096 

ph: (312) 372-2000 

fax: (312) 984-7700 

Counsel for Defendant Sanofi-Synthelabo, 

Inc. 

Bruce E. Fader 

Proskauer Rose LLP 

1585 Broadway 

New York, New York 10036 

ph: (212) 969-3000 

fax: (212) 969-2900 

Counsel for Defendant Sanofi-Synthelabo, 

Inc.

Case: 1:03-cv-07822 Document #: 473 Filed: 12/22/06 Page 7 of 8 PageID #:5190
CERTIFICATE OF SERVICE

I, Steven M. Evans, an attorney, certify that I caused copies of this JOINT MOTION 

TO SUSPEND PROCEEDINGS PENDING SETTLEMENT NEGOTIATIONS, to be 

served upon the following individuals on December 22, 2006: 

(By Facsimile) 

Stuart E. Pollack 

Patterson, Belknap, Webb & Tyler LLP 

1133 Avenue of the Americas 

New York, New York 10036 

ph: (212) 336-2000 

fax: (212) 336-2222 

direct fax: (212) 336-2848 

(By Facsimile) 

Raymond C. Perkins 

Winston & Strawn 

35 West Wacker Drive 

Chicago, Illinois 60601 

ph: (312) 558-5600 

fax: (312) 558-5700 

(By Facsimile) 

Richard C. Pettus, Esq. 

McDermott Will & Emery 

340 Madison Avenue, 17th Floor 

New York, New York 10017 

ph: (212) 547-5505 

fax: (212) 547-5444 

(By Facsimile) 

Lazar P. Raynal 

McDermott, Will & Emery LLP

227 West Monroe 

Chicago, Illinois 60606-5096 

ph: (312) 372-2000 

fax: (312) 984-7700 

(By Facsimile) 

Michael D. Kaminski 

Foley & Lardner, LLP 

3000 K Street, N.W. 

Suite 500 

Washington, D.C. 20007 

ph: (202) 672-5300 

fax: (202) 672-5399 

(By Facsimile) 

Gregory S. Norrod

Heidi L. Belongia 

Michael Houston 

Foley & Lardner, LLP 

321 North Clark Street 

Suite 2800 

Chicago, Illinois 60610 

ph: (312) 832-4500 

fax: (312) 832-4700

(By Facsimile) 

Bruce E. Fader 

Proskauer Rose LLP 

1585 Broadway 

New York, New York 10036 

ph: (212) 969-3000 

fax: (212) 969-2900

Case: 1:03-cv-07822 Document #: 473 Filed: 12/22/06 Page 8 of 8 PageID #:5191